160 Health International Ltd

160 Health International Ltd has a market price of 18.96 and a market cap of 6,379,145,277.6, with a price-to-book ratio of 26.69 and a price-to-tangible-book ratio of 26.69. The company's liquidity position is characterized by a current ratio of 1.4 and cash and equivalents of 398,806,000.0, indicating a relatively strong short-term liquidity position. However, the company has a negative operating cash flow of -114,438,000.0 and a free cash flow of -72,188,000.0, suggesting ongoing cash flow challenges. The company's profitability is weak, with a net income of -72,986,000.0 and an operating income of -74,444,000.0. The return on equity is -0.3053 and the return on assets is -0.096, both significantly below industry norms. The gross profit of 170,158,000.0 is also underperforming relative to the industry median, indicating potential inefficiencies in cost management or pricing. The company's capital structure is marked by a debt-to-equity ratio of 1.05, with long-term debt of 249,864,000.0 and total equity of 239,028,000.0. The company's revenue of 651,868,000.0 is concentrated in a single business segment, with no disclosed geographic diversification, suggesting a high concentration risk. The company's growth trajectory is uncertain, with no disclosed revenue growth or decline in the outlook. The capital expenditure of -4,151,000.0 is minimal, indicating limited investment in future growth. The company's risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's risk assessment remains stable, with no new risks identified in the latest filings.